PL1910370T3 - Monohydrat pirolo [1,2-b] pirazolu podstawionego pirydynochinoliną jako inhibitor tgf-beta - Google Patents
Monohydrat pirolo [1,2-b] pirazolu podstawionego pirydynochinoliną jako inhibitor tgf-betaInfo
- Publication number
- PL1910370T3 PL1910370T3 PL06774280T PL06774280T PL1910370T3 PL 1910370 T3 PL1910370 T3 PL 1910370T3 PL 06774280 T PL06774280 T PL 06774280T PL 06774280 T PL06774280 T PL 06774280T PL 1910370 T3 PL1910370 T3 PL 1910370T3
- Authority
- PL
- Poland
- Prior art keywords
- tgf
- pyridin
- beta inhibitor
- substituted pyrrolo
- pyrazole monohydrate
- Prior art date
Links
- JUJGNTINMISJQF-UHFFFAOYSA-N O.C1=CNN2C=CC=C21 Chemical class O.C1=CNN2C=CC=C21 JUJGNTINMISJQF-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- UMHSKYSHOIGDPE-UHFFFAOYSA-N pyridine;quinoline Chemical group C1=CC=NC=C1.N1=CC=CC2=CC=CC=C21 UMHSKYSHOIGDPE-UHFFFAOYSA-N 0.000 title 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70164105P | 2005-07-22 | 2005-07-22 | |
| EP20060774280 EP1910370B1 (en) | 2005-07-22 | 2006-06-29 | A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| PCT/US2006/025377 WO2007018818A1 (en) | 2005-07-22 | 2006-06-29 | A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1910370T3 true PL1910370T3 (pl) | 2015-09-30 |
Family
ID=37450942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06774280T PL1910370T3 (pl) | 2005-07-22 | 2006-06-29 | Monohydrat pirolo [1,2-b] pirazolu podstawionego pirydynochinoliną jako inhibitor tgf-beta |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7872020B2 (pl) |
| EP (1) | EP1910370B1 (pl) |
| JP (1) | JP5242391B2 (pl) |
| BR (1) | BRPI0613639A2 (pl) |
| CA (1) | CA2616196C (pl) |
| DK (1) | DK1910370T3 (pl) |
| ES (1) | ES2542425T3 (pl) |
| HR (1) | HRP20150474T1 (pl) |
| HU (1) | HUE025209T2 (pl) |
| IL (1) | IL188181A (pl) |
| MX (1) | MX2008001020A (pl) |
| PL (1) | PL1910370T3 (pl) |
| PT (1) | PT1910370E (pl) |
| RS (1) | RS53999B1 (pl) |
| SI (1) | SI1910370T1 (pl) |
| WO (1) | WO2007018818A1 (pl) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR081810A1 (es) | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | Piridinilpirazoles biciclicos |
| RU2612958C2 (ru) | 2011-07-13 | 2017-03-14 | Ск Кемикалз Ко., Лтд. | 2-пиридилзамещенные имидазолы в качестве ингибиторов alk5 и/или alk4 |
| EP2917365B1 (en) | 2012-11-12 | 2020-03-11 | Institució Catalana de Recerca i Estudis Avançats | Methods and kits for the prognosis of colorectal cancer |
| BR112015023261A2 (pt) | 2013-03-14 | 2017-07-18 | Massachusetts Inst Technology | composições e métodos para expansão e cultura de células-tronco epiteliais |
| CN107073042A (zh) | 2014-09-03 | 2017-08-18 | 布里格海姆妇女医院公司 | 用于产生内耳毛细胞来治疗听力损失的组合物、系统和方法 |
| WO2016123573A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| EP3277673B1 (en) | 2015-04-01 | 2022-05-04 | Rigel Pharmaceuticals, Inc. | Tgf-beta inhibitors |
| JP6980534B2 (ja) | 2015-06-25 | 2021-12-15 | ザ チルドレンズ メディカル センター コーポレーション | 造血幹細胞の増大、富化、および維持に関する方法および組成物 |
| US10450318B2 (en) | 2015-12-15 | 2019-10-22 | Bristol-Myers Squibb Company | CXCR4 receptor antagonists |
| CA3010610A1 (en) | 2016-01-08 | 2017-07-13 | The Brigham And Women's Hospital, Inc. | Production of differentiated enteroendocrine cells and insulin producing cells |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| US10604528B2 (en) | 2016-07-07 | 2020-03-31 | Crystal Pharmaceutical (Suzhou) Co., Ltd. | Galunisertib crystalline form, preparation method thereof and use thereof |
| WO2018068759A1 (zh) | 2016-10-14 | 2018-04-19 | 江苏恒瑞医药股份有限公司 | 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用 |
| AU2017386417B2 (en) | 2016-12-30 | 2022-07-14 | Frequency Therapeutics, Inc. | 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
| WO2018165979A1 (zh) * | 2017-03-17 | 2018-09-20 | 杭州领业医药科技有限公司 | 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的晶型及其制备方法和药物组合物 |
| WO2018170724A1 (zh) | 2017-03-21 | 2018-09-27 | 杭州领业医药科技有限公司 | 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的共晶，其制备方法和药物组合物 |
| WO2019042383A1 (zh) * | 2017-08-31 | 2019-03-07 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| WO2019105082A1 (zh) * | 2017-11-30 | 2019-06-06 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| WO2019137027A1 (zh) * | 2018-01-12 | 2019-07-18 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| ES3038913T3 (en) | 2018-03-20 | 2025-10-15 | Icahn School Med Mount Sinai | Beta-carboline derivatives as dyrk1a inhibitors for the treatment of e.g. diabetes |
| US20210254006A1 (en) | 2018-06-06 | 2021-08-19 | Ideaya Biosciences, Inc. | Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds |
| WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
| WO2020037323A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
| CA3124700A1 (en) | 2018-12-31 | 2020-07-09 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| CN115282280A (zh) * | 2022-08-12 | 2022-11-04 | 中国科学技术大学 | TGF-β1信号抑制剂的新用途 |
| KR20260019479A (ko) | 2023-05-04 | 2026-02-10 | 레볼루션 메디슨즈, 인크. | Ras 관련 질환 또는 장애를 위한 병용 요법 |
| GB202309553D0 (en) | 2023-06-24 | 2023-08-09 | Ucl Business Ltd | Compostions and uses thereof |
| CN121889155A (zh) | 2023-08-07 | 2026-04-17 | 锐新医药公司 | 用于治疗ras蛋白相关疾病或病症的rmc-6291 |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
| WO2026090116A2 (en) | 2024-10-21 | 2026-04-30 | Revolution Medicines, Inc. | Ras inhibitors |
| US20260108528A1 (en) | 2024-10-22 | 2026-04-23 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2026090245A1 (en) | 2024-10-22 | 2026-04-30 | Revolution Medicines, Inc. | Use of ras inhibitors for treating cancer |
| WO2026106912A1 (en) | 2024-11-12 | 2026-05-21 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026112260A1 (en) | 2024-11-21 | 2026-05-28 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026122764A2 (en) | 2024-12-06 | 2026-06-11 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026128688A2 (en) | 2024-12-13 | 2026-06-18 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026161839A1 (en) | 2025-01-27 | 2026-07-30 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1397364T1 (sl) * | 2001-05-24 | 2007-12-31 | Lilly Co Eli | Novi pirolni derivati kot farmacevtske uäśinkovine |
| EP1567528A1 (en) * | 2002-11-21 | 2005-08-31 | Eli Lilly And Company | Mixed lineage kinase modulators |
| UA80571C2 (en) | 2002-11-22 | 2007-10-10 | Lilly Co Eli | Quinolinyl-pyrrolopyrazoles |
-
2006
- 2006-06-29 CA CA2616196A patent/CA2616196C/en not_active Expired - Fee Related
- 2006-06-29 PT PT67742809T patent/PT1910370E/pt unknown
- 2006-06-29 SI SI200631924T patent/SI1910370T1/sl unknown
- 2006-06-29 EP EP20060774280 patent/EP1910370B1/en not_active Expired - Lifetime
- 2006-06-29 PL PL06774280T patent/PL1910370T3/pl unknown
- 2006-06-29 HR HRP20150474TT patent/HRP20150474T1/hr unknown
- 2006-06-29 WO PCT/US2006/025377 patent/WO2007018818A1/en not_active Ceased
- 2006-06-29 DK DK06774280.9T patent/DK1910370T3/en active
- 2006-06-29 MX MX2008001020A patent/MX2008001020A/es active IP Right Grant
- 2006-06-29 ES ES06774280.9T patent/ES2542425T3/es not_active Expired - Lifetime
- 2006-06-29 RS RS20150319A patent/RS53999B1/sr unknown
- 2006-06-29 HU HUE06774280A patent/HUE025209T2/en unknown
- 2006-06-29 JP JP2008522796A patent/JP5242391B2/ja not_active Expired - Fee Related
- 2006-06-29 BR BRPI0613639-7A patent/BRPI0613639A2/pt not_active Application Discontinuation
- 2006-06-29 US US11/995,938 patent/US7872020B2/en not_active Expired - Fee Related
-
2007
- 2007-12-17 IL IL188181A patent/IL188181A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RS53999B1 (sr) | 2015-10-30 |
| BRPI0613639A2 (pt) | 2012-02-22 |
| JP2009502780A (ja) | 2009-01-29 |
| CA2616196A1 (en) | 2007-02-15 |
| EP1910370B1 (en) | 2015-04-22 |
| HUE025209T2 (en) | 2016-03-29 |
| ES2542425T3 (es) | 2015-08-05 |
| MX2008001020A (es) | 2008-03-25 |
| PT1910370E (pt) | 2015-06-30 |
| EP1910370A1 (en) | 2008-04-16 |
| SI1910370T1 (sl) | 2015-06-30 |
| CA2616196C (en) | 2012-08-21 |
| IL188181A0 (en) | 2008-03-20 |
| US7872020B2 (en) | 2011-01-18 |
| HRP20150474T1 (xx) | 2015-06-05 |
| DK1910370T3 (en) | 2015-06-08 |
| WO2007018818A1 (en) | 2007-02-15 |
| JP5242391B2 (ja) | 2013-07-24 |
| US20100120854A1 (en) | 2010-05-13 |
| IL188181A (en) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188181A0 (en) | A pyridin quinolin substituted pyrrolo [1,2-b]pyrazole monohydrate as tgf-beta inhibitor | |
| PL1904494T3 (pl) | Związki imidazo[1,2-A]pirydynowe jako inhibitory VEGF-R2 | |
| EG25765A (en) | Pyrido [2,3-B] pyrazine derivatives useful as herbicidal compounds | |
| IL188248A0 (en) | Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors | |
| IL179406A0 (en) | Tetrahydro-imidazo[1,5-a] pyridin derivatives as aldosterone synthase inhibitors | |
| SI1966202T1 (sl) | S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze | |
| SI1697356T1 (sl) | Pirido(2,3-d)pirimidin-2,4-diamini kot zaviralci PDE 2 | |
| IL197393A0 (en) | Pyridin-4-yl derivatives as immunomodulating agents | |
| PT2124944E (pt) | Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase | |
| PL1711481T3 (pl) | Krystaliczny monohydrat jako inhibitor kinazy | |
| PL1789041T3 (pl) | Pochodne arylopirydyny jako inhibitory 11-beta-HSD1 | |
| PL1797042T3 (pl) | Pochodne indozolonu jako inhibitory 11B-HSD1 | |
| LT1773768T (lt) | Pirolo dariniai, kaip farmaciniai agentai | |
| IL195915A0 (en) | 3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors | |
| ZA200802690B (en) | Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors | |
| ZA200904440B (en) | 6-Benzyl-2,3,4,7-Tetrahydro-indolo [2,3-C] quinoline compounds useful as PDE5 inhibitors | |
| IL190456A0 (en) | Pyrazolo[4,3-d]pirimidin-5-yl)derivative used as pde5 inhibitors | |
| ZA200804104B (en) | Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors | |
| ZA200608769B (en) | Imidazopyridine compound | |
| HK1138515A (en) | Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors | |
| HK1099769A (en) | Imidazopyridine compound | |
| CY1116567T1 (el) | ΕΝΑ ΠΥΡΙΔΙΝΟΚΙΝΟΛΙΝΟ-ΥΠΟΚΑΣΤΕΣΤΗΜΕΝΟ ΜΟΝΟΕΝΥΔΡΟ ΠΥΡΡΟΛΟ [1,2-B]ΠΥΡΑΖΟΛΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ ΤΟΥ TGF-β | |
| HK1102588A (en) | Tetrahydro-imidazo (1,5-a) pyridin derivatives as aldosterone synthase inhibitors | |
| IL178688A0 (en) | THIENO [3,2-b] PYRIDINE-6-CARBONITRILES AS PROTEIN KINASE INHIBITORS | |
| HK1123051A (en) | Octahydro-pyrrolo[3,4-b]pyrrole derivatives |